RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 95 filers reported holding RELAY THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $104 | -33.3% | 12,397 | 0.0% | 0.01% | -25.0% |
Q2 2023 | $156 | -23.5% | 12,397 | 0.0% | 0.01% | -25.0% |
Q1 2023 | $204 | +10.3% | 12,397 | 0.0% | 0.02% | +6.7% |
Q4 2022 | $185 | -99.9% | 12,397 | -2.7% | 0.02% | -40.0% |
Q3 2022 | $286,000 | +33.6% | 12,747 | 0.0% | 0.02% | +38.9% |
Q2 2022 | $214,000 | -44.0% | 12,747 | 0.0% | 0.02% | -33.3% |
Q1 2022 | $382,000 | -2.3% | 12,747 | 0.0% | 0.03% | +8.0% |
Q4 2021 | $391,000 | 0.0% | 12,747 | +2.8% | 0.02% | -10.7% |
Q3 2021 | $391,000 | -49.4% | 12,397 | -41.3% | 0.03% | -49.1% |
Q2 2021 | $773,000 | +5.9% | 21,121 | 0.0% | 0.06% | 0.0% |
Q1 2021 | $730,000 | -16.9% | 21,121 | 0.0% | 0.06% | -19.1% |
Q4 2020 | $878,000 | -2.4% | 21,121 | 0.0% | 0.07% | -17.1% |
Q3 2020 | $900,000 | – | 21,121 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Grace Capital | 183,112 | $5,665,000 | 3.48% |
Casdin Capital, LLC | 3,668,574 | $115,670,000 | 2.88% |
SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $879,843,000 | 2.73% |
BVF INC/IL | 2,049,113 | $64,609,000 | 2.52% |
Fernwood Investment Management, LLC | 185,063 | $5,835,000 | 2.00% |
EcoR1 Capital, LLC | 1,385,276 | $43,678,000 | 1.52% |
Boxer Capital, LLC | 1,294,132 | $40,804,000 | 1.42% |
Integral Health Asset Management, LLC | 140,000 | $4,414,000 | 1.27% |
Alphabet Inc. | 1,641,497 | $51,756,000 | 1.23% |
Bellevue Group AG | 3,755,962 | $118,426,000 | 1.20% |